Pharvaris (PHVS) Receivables - Net (2019 - 2026)

Pharvaris (PHVS) posted Receivables - Net of $1.1 million for Q1 2026, up 75.16% on a QoQ basis from $648068.4 in Q4 2025, and up 85.07% year-over-year from $613377.0 in Q1 2025.

Pharvaris (PHVS) Receivables - Net (2019 - 2026) Analysis & Trends

Pharvaris' Receivables - Net history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • Quarterly Receivables - Net rose 85.07% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 85.07% YoY) and the FY2025 annual result came in at $5.1 million, up 61.34% from the prior year.
  • Receivables - Net was $1.1 million for Q1 2026 at Pharvaris, up from $648068.4 in the prior quarter.
  • Across five years, Receivables - Net topped out at $1.1 million in Q1 2026 and bottomed at $336205.7 in Q3 2023.
  • A 5-year average of $539213.5 and a median of $472442.4 in 2023 frame the typical range for Receivables - Net.
  • Annual changes were most pronounced in 2022 — Receivables - Net slumped 58.74% — and 2024, when it soared 110.82%.
  • Pharvaris' Receivables - Net stood at $390212.0 in 2022, then rose by 16.77% to $455645.5 in 2023, then advanced by 7.37% to $489239.3 in 2024, then surged by 32.46% to $648068.4 in 2025, then surged by 75.16% to $1.1 million in 2026.
  • Business Quant data shows PHVS's Receivables - Net at $1.1 million in Q1 2026, $648068.4 in Q4 2025, and $601795.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Pharvaris 2.17 Bn 1.88 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.14 Mn
Mar 31, 2026 1.14 Mn
Dec 31, 2025 648,068.42
Dec 31, 2025 648,068.42
Jun 30, 2025 601,795.05
Jun 30, 2025 601,795.05
Mar 31, 2025 613,376.96
Mar 31, 2025 613,376.96
Dec 31, 2024 489,239.31
Dec 31, 2024 489,239.31
Sep 30, 2024 708,782.08
Sep 30, 2024 708,782.08
Jun 30, 2024 554,924.48
Jun 30, 2024 554,924.48
Mar 31, 2024 394,426.45
Mar 31, 2024 394,426.45
Dec 31, 2023 455,645.49
Dec 31, 2023 455,645.49
Sep 30, 2023 336,205.73
Sep 30, 2023 336,205.73